BAP1 and familial pancreatic carcinoma: Although BAP1 is not part of the Hippo pathway, a recent report highlights that BAP1 functions as a stabiliser of LATS1 and LATS2 via its deubiquitinase activity in a pancreatic cancer cell‐line model, hence acting as an activator of the Hippo kinase module (Figure 1A).48